SALL4 and hepatocellular carcinoma: Our recent study based on high-throughput chemical screening showed that oligomycin, as well as three other ETC inhibitors, significantly repressed SALL4-expressing HCC cell proliferation and patient-derived HCC xenograft tumor growth41.